Dr Martens PLC
LSE:DOCS

Watchlist Manager
Dr Martens PLC Logo
Dr Martens PLC
LSE:DOCS
Watchlist
Price: 56.4 GBX 4.25% Market Closed
Market Cap: 542.5m GBX
Have any thoughts about
Dr Martens PLC?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

DOCS Price Targets Summary
Dr Martens PLC

Wall Street analysts forecast DOCS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DOCS is 77.01 GBX with a low forecast of 60.6 GBX and a high forecast of 99.75 GBX.

DOCS Lowest Forecast
Wall Street Target
60.6 GBX
7% Upside
DOCS Average Forecast
Wall Street Target
77.01 GBX
37% Upside
DOCS Highest Forecast
Wall Street Target
99.75 GBX
77% Upside
Lowest
Price Target
60.6 GBX
7% Upside
Average
Price Target
77.01 GBX
37% Upside
Highest
Price Target
99.75 GBX
77% Upside
Dr Martens PLC Competitors:
Price Targets
C
CAMPUS
Campus Activewear Ltd
20% Upside
V
VULC3
Vulcabras SA
42% Upside
9910
Feng Tay Enterprises Co Ltd
22% Upside
SKX
Skechers USA Inc
36% Upside
C
CAMPUS
Campus Activewear Ltd
20% Upside
V
VULC3
Vulcabras SA
42% Upside
9910
Feng Tay Enterprises Co Ltd
22% Upside
SKX
Skechers USA Inc
36% Upside
GRND3
Grendene SA
45% Upside
C
CCC
CCC SA
45% Downside
ONON
On Holding AG
4% Upside
S
1836
Stella International Holdings Ltd
20% Upside

Revenue
Forecast

Revenue Estimate
Dr Martens PLC

For the last 5 years the compound annual growth rate for Dr Martens PLC's revenue is 14%. The projected CAGR for the next 3 years is 2%.

14%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dr Martens PLC

For the last 5 years the compound annual growth rate for Dr Martens PLC's operating income is 11%. The projected CAGR for the next 3 years is -1%.

11%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dr Martens PLC

For the last 5 years the compound annual growth rate for Dr Martens PLC's net income is 32%. The projected CAGR for the next 3 years is -1%.

32%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

See Also

Summary
DOCS intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOCS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOCS stock valuation using valuation multiples.
Wall Street Estimates
DOCS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOCS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DOCS's stock price target?
Price Target
77.01 GBX

According to Wall Street analysts, the average 1-year price target for DOCS is 77.01 GBX with a low forecast of 60.6 GBX and a high forecast of 99.75 GBX.

What is Dr Martens PLC's Revenue forecast?
Projected CAGR
2%

For the last 5 years the compound annual growth rate for Dr Martens PLC's revenue is 14%. The projected CAGR for the next 3 years is 2%.

What is Dr Martens PLC's Operating Income forecast?
Projected CAGR
-1%

For the last 5 years the compound annual growth rate for Dr Martens PLC's operating income is 11%. The projected CAGR for the next 3 years is -1%.

What is Dr Martens PLC's Net Income forecast?
Projected CAGR
-1%

For the last 5 years the compound annual growth rate for Dr Martens PLC's net income is 32%. The projected CAGR for the next 3 years is -1%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.